KRTX
Karuna Therapeutics Inc
$329.83
Earnings Summary
Revenue | $0Mn |
Net Profits | $-113.82Mn |
Net Profit Margins | -Inf% |
Highlights
Karuna Therapeutics Inc’s revenue fell -100% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Karuna Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.
Karuna Therapeutics Inc’s net profit fell -49.35% since last year same period to $-113.82Mn in the Q4 2023. On a quarterly growth basis, Karuna Therapeutics Inc has generated 4.45% jump in its net profits since last 3-months.
Karuna Therapeutics Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Karuna Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Karuna Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -2.96 |
EPS Estimate Current Year | -2.96 |
Highlights
Karuna Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -2.96 - a -11.7% fall from last quarter’s estimates.
Karuna Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -2.96.
Key Ratios
Key ratios of the Karuna Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -3.01 |
Highlights
Karuna Therapeutics Inc’s earning per share (EPS) fell -35.59% since last year same period to -3.01 in the Q4 2023. This indicates that the Karuna Therapeutics Inc has generated -35.59% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-03 | -2.78 | -2.75 | 1.08% |
2023-05-04 | -2.76 | -2.8 | -1.45% |
2024-02-22 | -2.65 | -3.01 | -13.58% |
2023-11-02 | -2.74 | -3.16 | -15.33% |
₹0 US Stocks a/c Opening Fee